Key Agreement Details
Aarti Industries Limited has entered into a 10+ year dedicated manufacturing and supply agreement with a leading global speciality chemical company. This agreement establishes a new customer relationship for AIL and supports the customer's expanding requirements in India.
Financial Terms
The agreement offers an estimated cumulative revenue potential of ₹1,500 crores (approximately US$150 million) over the contract period.
Manufacturing Arrangement
AIL will set up, commission, and operate a dedicated manufacturing facility in India for a speciality chemical used in high-performance applications. The facility will be based on the customer's proprietary process technology. The arrangement includes a structured financial arrangement to finance CAPEX of less than US$25 million.
Operational Timeline
Commercial operations are expected to commence in FY2028–29, subject to applicable approvals.
Strategic Rationale
The model combines global technology with AIL's process scale-up, engineering, and operating capabilities to provide a critical manufacturing outsourcing solution to global companies. By localizing manufacturing through a dedicated Indian setup, this arrangement will support supply-chain resilience and the customer's growth plans in India.
Management Commentary
Mr. Suyog Kotecha, Managing Director and Chief Executive Officer of Aarti Industries Limited, stated that the agreement brings a new global customer into AIL's portfolio and reflects confidence in their ability to establish and operate dedicated manufacturing assets to global standards. He noted that the long-term domestic supply arrangement provides sustained visibility while creating a capital-efficient platform for growth, serving as a foundation to expand the engagement as the customer's India requirements grow.